HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 意见
• 07/03/23
0
0
嵌入
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论